Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

4.5K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.5K
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

217
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
217
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.5K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.5K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

129
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
129
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

471
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
471
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

2.9K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Emulsion-Templated Gel Embedding: A Microfluidics-Free Method for Scalable Cell Encapsulation in Hydrogel Microcapsules.

ACS biomaterials science & engineering·2026
Same author

A Counterfactual Framework for Directional Cell-Cell Interaction Analysis in Spatial Transcriptomics.

bioRxiv : the preprint server for biology·2026
Same author

Regulation of the lncRNA <i>malat1</i>/Egr1 axis by Wnt, Notch, and TGF-β signaling: a key mechanism in retina regeneration.

NAR molecular medicine·2025
Same author

Endofungal bacteria: Emerging paradigms and future directions.

Microbiological research·2025
Same author

Physio-biochemical and molecular analyses decipher distinct dehydration stress responses in contrasting genotypes of foxtail millet (Setaria italica L.).

Journal of plant physiology·2025
Same author

A long tail of truth and beauty: A zigzag pattern of feather formation determines the symmetry, complexity, and beauty of the peacock's tail.

F1000Research·2025

Related Experiment Video

Updated: Apr 15, 2026

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
12:40

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System

Published on: December 7, 2012

29.8K

Potential pharmacological interventions against hematotoxicity: an overview.

Pooja Shukla1, Rama Singh

  • 1Academy for Scientific and Innovative Research, New Delhi 110 001, India.

Expert Review of Hematology
|April 7, 2015
PubMed
Summary

Chemotherapy causes oxidative stress, harming blood cells. This review identifies antioxidant compounds to combat chemotherapy-induced hematotoxicity, offering a potential strategy to protect patients from blood-related side effects.

Keywords:
anti-hematotoxiccancerchemotherapeutichematotoxicityoxidative stress

More Related Videos

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
08:32

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

4.6K
Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
03:40

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis

Published on: December 8, 2023

2.1K

Related Experiment Videos

Last Updated: Apr 15, 2026

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
12:40

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System

Published on: December 7, 2012

29.8K
CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
08:32

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

4.6K
Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
03:40

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis

Published on: December 8, 2023

2.1K

Area of Science:

  • Biomedical Science
  • Pharmacology
  • Toxicology

Background:

  • Chemotherapy regimens induce significant oxidative stress, leading to adverse effects on healthy tissues, particularly blood cells.
  • Hematotoxicity is an unavoidable side effect of many chemotherapeutic agents.
  • A lack of consolidated information exists regarding interventions against chemotherapy-induced hematotoxicity.

Purpose of the Study:

  • To review potential anti-hematotoxic compounds based on their antioxidant properties.
  • To consolidate existing literature on interventions against chemotherapy-induced blood toxicity.
  • To explore the mechanistic pathways of identified antioxidant compounds.

Main Methods:

  • Literature mining and review of existing studies on oxidative stress and chemotherapy.
  • Identification of compounds with demonstrated antioxidant potential.
  • Analysis of mechanistic pathways involved in antioxidant activity against hematotoxicity.

Main Results:

  • Several compounds with antioxidant potential were identified as possible interventions against hematotoxicity.
  • The review highlights the role of oxidative stress in chemotherapy-induced blood damage.
  • Mechanistic pathways of these compounds offer insights into their protective effects.

Conclusions:

  • Supplementing patients with identified anti-hematotoxic compounds may mitigate chemotherapy's toxic burden on blood cells.
  • Further research into these compounds could lead to novel strategies for managing chemotherapy side effects.
  • Consolidating this information provides a valuable resource for clinicians and researchers in the field.